News US drug revenues far exceed R&D spend - report Analysis questions industry's rationale for high US prices.
News Roche breast cancer trial success could kill Puma's rival Perjeta trial success sends rival biotech's share price crashing.
News UK space plans take flight - and medicines could benefit Government hopes spaceport plans will boost biotech research
News AZ sells US/Canada rights for old breast cancer drug AstraZeneca has sold US and Canadian rights to its older breast cancer drug Zoladex to TerSera Therapeutics in a deal worth up to $320 million.
News Merck's failure casts gloom over remaining BACE Alzheimer's ... But trial in patients in early stage of the disease continues.
News Ergomed hails insomnia and cancer deals UK biotech has stake in two potentially lucrative drugs thanks to hybrid business model
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
